TVGN logo

Tevogen Bio Holdings (TVGN) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

Total Assets

$4.3 M(+29.6%)$3.3 M(-1.6%)$3.4 M(-80.3%)$17.0 M-$5.6 M-$357.1 M

Current Assets

$3.5 M(+44.2%)$2.4 M(+1.9%)$2.4 M(+574.5%)$355.8 K-$3.7 M-$274.4 K

Non Current Assets

$761.8 K(-11.8%)$863.5 K(-10.4%)$963.5 K(-94.2%)$16.7 M-$2.0 M-$356.9 M

Total Liabilities

$10.5 M(-4.2%)$10.9 M(+19.4%)$9.2 M(-48.3%)$17.7 M-$92.5 M-$15.1 M

Current Liabilities

$10.4 M(-1.9%)$10.6 M(+18.7%)$8.9 M(+197.5%)$3.0 M-$64.9 M-$350.5 K

Long Term Liabilities

$64.2 K(-80.7%)$332.2 K(+45.8%)$227.8 K(-98.5%)$14.7 M-$27.6 M-$14.7 M

Shareholders Equity

-$6.2 M(+18.9%)-$7.6 M(-31.6%)-$5.8 M(-734.0%)-$695.8 K--$86.9 M-$342.1 M

Book Value

-$13.0 M(-24.5%)-$10.4 M(+14.6%)-$12.2 M(-1655.6%)-$695.8 K--$86.9 M-$342.1 M

Working Capital

-$6.9 M(+15.6%)-$8.2 M(-24.9%)-$6.5 M(-146.9%)-$2.6 M--$61.3 M--$76.1 K

Cash And Cash Equivalents

$2.3 M(+105.3%)$1.1 M(-13.8%)$1.3 M(+14876.1%)$8800.0-$3.5 M-$129.2 K

Accounts Payable

$5.8 M(-12.4%)$6.7 M(+27.9%)$5.2 M(+356.2%)$1.1 M-$1.1 M-$210.5 K

Accounts Receivable

--------

Short Term Debt

$2.9 M(+52.2%)$1.9 M(+0.4%)$1.9 M(+17.1%)$1.6 M-$63.2 M-$278.2 K

Long Term Debt

$42.6 K(-56.0%)$96.8 K(-42.0%)$166.8 K--$27.6 M-$39.7 M

Total Debt

$3.0 M(+47.0%)$2.0 M(-3.0%)$2.1 M(+27.4%)$1.6 M(+100.0%)$0.0(-100.0%)$90.8 M(+100.0%)$0.0(-100.0%)$40.0 M

Debt To Equity

-0.5(-84.6%)-0.3(+27.8%)-0.4(+84.7%)-2.4--1.1-0.1

Current Ratio

0.3(+47.8%)0.2(-14.8%)0.3(+125.0%)0.1-0.1-0.8

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$103.9 M(-6.0%)-$98.1 M(-10.9%)-$88.4 M(-408.6%)-$17.4 M--$92.1 M--$14.8 M

PB Ratio

-10.2(+14.1%)-11.8(+76.6%)-50.5(+98.0%)-2529.2----

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

EPS

-$0.0(+25.0%)-$0.0(+84.6%)-$0.3(-172.4%)$0.4(+1553.8%)-$0.0(+82.4%)-$0.1(+46.0%)-$0.3-

TTM EPS

$0.0(-15.4%)$0.0(+152.2%)-$0.1(0%)-$0.1(+84.5%)-$0.4(-6.2%)-$0.4(-54.0%)-$0.3-

Revenue

--------

TTM Revenue

--------

Total Expenses

$6.1 M(-29.2%)$8.6 M(-70.9%)$29.5 M(+747.3%)-$4.6 M(-296.1%)$2.3 M(+6.4%)$2.2 M(-6.0%)$2.3 M-

Operating Expenses

$6.1 M(-29.2%)$8.6 M(-70.9%)$29.5 M(+747.3%)-$4.6 M(-296.1%)$2.3 M(+6.4%)$2.2 M(-6.0%)$2.3 M-

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$6.1 M(+29.2%)-$8.6 M(+70.9%)-$29.5 M(-747.3%)$4.6 M(+296.1%)-$2.3 M(-6.4%)-$2.2 M(+6.0%)-$2.3 M-

TTM Operating Profit

-$39.6 M(-10.5%)-$35.9 M(-21.8%)-$29.5 M(-1195.8%)-$2.3 M(+66.7%)-$6.8 M(-51.6%)-$4.5 M(-94.0%)-$2.3 M-

Operating Margin

--------

Net Income

-$5.9 M(+39.1%)-$9.7 M(-185.8%)$11.3 M(-80.2%)$56.8 M(+1554.0%)-$3.9 M(+82.4%)-$22.2 M(+27.9%)-$30.8 M-

TTM Net Income

$52.5 M(-3.6%)$54.5 M(+29.8%)$42.0 M(+62345.6%)-$67.4 K(+99.9%)-$56.8 M(-7.4%)-$52.9 M(-72.1%)-$30.8 M-

Net Margin

--------

EBIT

-$5.9 M(+31.7%)-$8.6 M(-175.3%)$11.4 M(-79.7%)$56.1 M(+1657.4%)-$3.6 M(-65.0%)-$2.2 M(+92.8%)-$30.5 M-

TTM EBIT

$53.1 M(-4.1%)$55.4 M(-10.4%)$61.8 M(+210.6%)$19.9 M(+154.9%)-$36.3 M(-11.0%)-$32.7 M(-7.2%)-$30.5 M-

EBITDA

-$5.7 M(+34.3%)-$8.6 M(-174.7%)$11.5 M(-79.5%)$56.1 M(+1747.9%)-$3.4 M(-56.0%)-$2.2 M(+92.8%)-$30.4 M-

TTM EBITDA

$53.4 M(-4.0%)$55.7 M(-10.3%)$62.1 M(+207.6%)$20.2 M(+156.1%)-$36.0 M(-10.5%)-$32.6 M(-7.2%)-$30.4 M-

Selling, General & Administrative Expenses

$2.8 M(-36.9%)$4.5 M(-48.6%)$8.7 M(+917.9%)-$1.1 M(-188.1%)$1.2 M(+4.8%)$1.2 M(+18.0%)$977.1 K-

TTM SGA

$14.9 M(+12.1%)$13.3 M(+33.2%)$10.0 M(+339.8%)$2.3 M(-31.9%)$3.3 M(+56.7%)$2.1 M(+118.0%)$977.1 K-

Depreciation And Amortization

$218.9 K(+1372.7%)-$17.2 K(-117.5%)$98.3 K(+135.4%)-$277.5 K(-240.2%)$198.0 K(+1792.3%)-$11.7 K(-112.8%)$91.2 K-

TTM D&A

$22.5 K(+1306.3%)$1600.0(-77.5%)$7100.0(+100.0%)$0.0(-100.0%)$277.5 K(+249.1%)$79.5 K(-12.8%)$91.2 K-

Interest Expense

$12.5 K-$155.8 K(+124.6%)-$632.8 K(-311.0%)$299.9 K-$289.0 K-

TTM Interest Expense

-$464.5 K--$177.1 K(-303.4%)-$43.9 K(-107.5%)$588.9 K-$289.0 K-

Income Tax

--------

TTM Income Tax

--------

PE Ratio

12.7(-40.4%)21.2------

PS Ratio

--------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

Cash From Operations

-$3.8 M(-27.6%)-$3.0 M(-37.8%)-$2.2 M(-144.9%)$4.8 M(+367.7%)-$1.8 M(+18.8%)-$2.2 M(-1.9%)-$2.2 M-

TTM CFO

-$4.1 M(-94.2%)-$2.1 M(-56.1%)-$1.4 M(+1.0%)-$1.4 M(+77.8%)-$6.2 M(-41.0%)-$4.4 M(-101.9%)-$2.2 M-

Cash From Investing

$0.0(0%)$0.0(0%)$0.0(-100.0%)$343.0 M(+100.0%)$0.0(0%)$0.0(+100.0%)-$133.0 K-

TTM CFI

$343.0 M(0%)$343.0 M(0%)$343.0 M(+0.0%)$342.9 M(+257932.3%)-$133.0 K(0%)-$133.0 K(0%)-$133.0 K-

Cash From Financing

$5.0 M(+78.6%)$2.8 M(+15.3%)$2.4 M(+100.7%)-$345.1 M(-36427.5%)$950.0 K(+100.0%)$0.0(-100.0%)$2.5 M-

TTM CFF

-$334.9 M(+1.2%)-$338.9 M(+0.8%)-$341.7 M(-0.0%)-$341.7 M(-10003.2%)$3.5 M(+38.0%)$2.5 M(0%)$2.5 M-

Free Cash Flow

-$3.8 M(-27.6%)-$3.0 M(-37.8%)-$2.2 M(-143.7%)$5.0 M(+375.1%)-$1.8 M(+18.8%)-$2.2 M(+4.0%)-$2.3 M-

TTM FCF

-$4.0 M(-100.5%)-$2.0 M(-62.2%)-$1.2 M(+10.6%)-$1.4 M(+78.3%)-$6.3 M(-39.8%)-$4.5 M(-96.0%)-$2.3 M-

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------